Affiliation:
1. Global Analytical – Pharmaceutical Sciences & Innovation, Global Analytical Development, Global CMC Development Merck Serono S.p.A. (Affilitate of Merck KGaA, Darmstadt, Germany) Guidonia Montecelio Rome Italy
2. Bosch Global Software Technologies Private Limited Bangalore India
Abstract
AbstractChromatographic data processing has garnered attention due to multiple Food and Drug Administration 483 citations and warning letters, highlighting the need for a robust technological solution. The healthcare industry has the potential to greatly benefit from the adoption of digital technologies, but the process of implementing these technologies can be slow and complex. This article presents a “Digital by Design” managerial approach, adapted from pharmaceutical quality by design principles, for designing and implementing an artificial intelligence (AI)‐based solution for chromatography peak integration process in the healthcare industry. We report the use of a convolutional neural network model to predict analytical variability for integrating chromatography peaks and propose a potential GxP framework for using AI in the healthcare industry that includes elements on data management, model management, and human‐in‐the‐loop processes. The component on analytical variability prediction has a great potential to enable Industry 4.0 objectives on real‐time release testing, automated quality control, and continuous manufacturing.
Subject
Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference82 articles.
1. Abood D. Quilligan A. Narsalay R. &Sen A.(2019).How to successfully scale digital innovation to drive growth. Accenture.https://www.accenture.com/in-en/insights/industry-x-0/scaling-digital
2. Amazon Web Services. (2021).GxP systems on AWS.https://docs.aws.amazon.com/whitepapers/latest/gxp-systems-on-aws/gxp-systems-on-aws.html
3. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future
4. AI and big data will continue to disrupt pharma sector, says survey;Begley A.;European Pharmaceutical Review,2021
5. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献